Citation Impact

Citing Papers

p53: puzzle and paradigm.
1996 Standout
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Oncogenic forms of p53 inhibit p53-regulated gene expression
1992 Science
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma
2004
Isolation of genes differentially expressed in human primary myoblasts and embryonal rhabdomyosarcoma
1996
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
The role of transforming growth factor Β in glioma progression
1998
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
An immunochemical analysis of the human nuclear phosphoprotein p53
1992
Soft-Tissue Sarcomas in Adults
2005 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 Standout
Cooperative tumorigenic effects of germline mutations in Rb and p53
1994
Sunburn and p53 in the onset of skin cancer
1994 StandoutNature
Deficiency of SPARC suppresses intestinal tumorigenesis in APC Min/+ mice
2007 StandoutNobel
Definition of a consensus binding site for p53
1992 Standout
The MDM2 gene amplification database
1998
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
G1 phase progression: Cycling on cue
1994 Standout
TGFβ in Cancer
2008 Standout
p73 is a human p53-related protein that can induce apoptosis
1997 StandoutNatureNobel
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
p53 function and dysfunction
1992 Standout
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 StandoutNature
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
1996
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 Standout
Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications
2000
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
1994 Standout
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
1995 Standout
The first 30 years of p53: growing ever more complex
2009 Standout
DNA methylation and cancer
2002
p53 Mutations in Human Cancers
1991 StandoutScience
Identification of a Cyclin-cdk2 Recognition Motif Present in Substrates and p21-Like Cyclin-Dependent Kinase Inhibitors
1996 StandoutNobel
Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes
2011
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.
1994 StandoutNobel
The p53-mdm-2 autoregulatory feedback loop.
1993 Standout
The Transcription Factor E2F-1 Is a Downstream Target of RB Action
1995 StandoutNobel
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
The retinoblastoma protein and cell cycle control
1995 Standout
Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes
1999 StandoutNobel
Identification of p53 as a Sequence-Specific DNA-Binding Protein
1991 Science
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
1994 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
1994
Cyclin D1 Is Dispensable for G1 Control in Retinoblastoma Gene-Deficient Cells Independently of cdk4 Activity
1995
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
1996 StandoutScience
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses.
1992
A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.
1991 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout

Works of Stuart Moss being referenced

Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
1990
The Circadian Clock Protein BMAL1 Is Necessary for Fertility and Proper Testosterone Production in Mice
2008
Rankless by CCL
2026